title: Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma.
authors.affiliation: Department of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan. Electronic address: mise@chiba-cc.jp.
authors.forename: Mikiko
authors.initials: M
authors.lastname: Ise
authors.affiliation: Department of Laboratory Medicine, Chiba Cancer Center, Chiba, Japan.
authors.forename: Keiko
authors.initials: K
authors.lastname: Matsubayashi
authors.affiliation: Department of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Tsujimura
authors.affiliation: Department of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
authors.forename: Kyoya
authors.initials: K
authors.lastname: Kumagai
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000235:genetics / Q000378:metabolism*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015415:Biomarkers; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D057915:Drug Substitution; D017809:Fatal Outcome; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D051997:ADP-ribosyl Cyclase 1; D008558:Melphalan; D011241:Prednisone
keywords: CD138; CDC; Cytogenetic abnormality; Daratumumab; Monoclonal antibody